Advocacy Actions
Meetings with DG Enter B4 on on the Position Paper 2014/2015 and updates of Automotive Market
Meeting started with the introduction on the table and a briefing on the Position Paper 2014/2015, as well as the updates of automotive market and auto sector in general to DG ENTR.
Read moreMeeting with Mr. Kostas Glinos, Head of Unit for Strategy on International Cooperation, DG Innovation & Research
Meeting with Mr. Kostas Glinos, Head of Unit for Strategy on International Cooperation, DG Innovation & Research
Read moreExclusive Dialogue with NDRC: Training on Anti-Monopoly Law Enforcement
On 22nd January, the European Chamber facilitated a training on the Anti-Monopoly Law, provided by Deputy Director General Li Qing from the NDRC’s Price Supervision and Anti-Monopoly Bureau and Mr. Wan Jiang from the Bureau's Legal Affairs Division.
Read moreJoint Automotive and Auto Components Working Group Meeting
Outlook Chinese Passenger Cars in 2015 and Beyond
Read moreMeeting with Dr. Cao Lei on Disclosure of Repairing and Maintenance Information (RMI)
Call for Comments on Disclosure of Repairing and Maintenance Information (RMI)
Read moreSubmit Comments/Recommendations to CFDA on the Draft Guidance for Medical Software Evaluation
Submit Comments/Recommendations to CFDA on the Draft Guidance for Medical Software Evaluation
Read moreSubmit Comments/Recommendations to MOT on Disclosure of Repairing and Maintenance Information (RMI)
Submit Comments/Recommendations to MOT on Disclosure of Repairing and Maintenance Information (RMI)
Read moreMeeting with China Association of Medical Equipment (CAME)
COCIR, MITA and CAME exchanged opinions about delelopmtent of the Medical Imaging Industry as well as "Buy China" Initatives of the NHFPC.
Read moreMeeting with Medical Imaging & Technology Alliance (MITA)
COCIR and MITA agreed to have regular meetings (monthly) to 1) exchange industry updates 2) discuss joint efforts on concrete industry issues if it’s appropriate 3) align lobby points with the Chinese authorities, eg. for JCCT from US side, and EU-China Regulators Dialogue.
Read more